Pierre Beaurang, Chief Business Officer at Nurix Therapeutics, Inc. (NRIX), sold 14,300 shares at $26.87 ($378K) on 2021-05-10, disclosed to the SEC on 2021-05-11.
Open-market sale of $378k NRIX by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.07 | 4,299 | $112K | 29.7% |
| 2 | $26.07 | 4,299 | $112K | 29.7% |
| 3 | $26.87 | 2,501 | $67K | 17.8% |
| 4 | $26.87 | 2,501 | $67K | 17.8% |
| 5 | $27.66 | 700 | $19K | 5.1% |
| Total | $26.43 avg | 14,300 |
| $378K |
| 100% |
| Filing → |
| NRIX | SELL | 2021-06-11 | $220K | — | Filing → |
| NRIX | SELL | 2021-04-13 | $394K | — | Filing → |
| NRIX | SELL | 2021-03-09 | $548K | — | Filing → |